Alveolar soft part sarcoma presenting as a breast metastasis in a patient with a history of thyroid cancer: a case report

被引:0
作者
Bychkov, Andrey [1 ]
Sampatanukul, Pichet [1 ]
机构
[1] Chulalongkorn Univ, Dept Pathol, Fac Med, Bangkok 10330, Thailand
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2015年 / 8卷 / 08期
关键词
Alveolar soft part sarcoma; breast metastasis; thyroid cancer; biopsy; TFE3; EXPRESSION; NEOPLASMS; GENE; MYOD1;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastases to the breast are uncommon, accounting for 0.5% of breast tumors, and most of them are originated from lymphoma, melanoma and carcinomas of various organs. Alveolar soft part sarcoma ( ASPS) is a very rare neoplasm that is usually found in the lower extremities. Lungs are the common site of dissemination and may represent initial manifestation of disease. We report a clinically unsuspected case of ASPS presenting as a breast metastasis in a 25-year-old woman. The patient's medical history was notable for a thyroid cancer treated by surgery and radioiodine ablation 2 years ago. Core needle biopsy of slowly growing breast mass yielded polygonal cells with abundant eosinophilic cytoplasm arranged into solid pattern. Differential diagnosis between apocrine cell carcinoma, paraganglioma, granular cell tumor, neuroendocrine carcinoma, ASPS and metastatic hepatocellular and renal cell carcinoma was rendered by immunohistochemistry. Strong nuclear TFE3 immunoreactivity confirmed a diagnosis of ASPS. Retrospectively a primary tumor was found in the thigh. Most likely, ASPS and thyroid cancer in the patient were growing synchronously and independently.
引用
收藏
页码:9731 / 9736
页数:6
相关论文
共 36 条
  • [1] Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions -: A sensitive and specific immunohistochemical assay
    Argani, P
    Lal, P
    Hutchinson, B
    Lui, MY
    Reuter, VE
    Ladanyi, M
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) : 750 - 761
  • [2] A proposed explanation for female predominance in alveolar soft part sarcoma - Noninactivation of X; Autosome translocation fusion gene?
    Bu, XD
    Bernstein, L
    [J]. CANCER, 2005, 103 (06) : 1245 - 1253
  • [3] Alveolar soft-part sarcoma: a review and update
    Folpe, A. L.
    Deyrup, A. T.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (11) : 1127 - 1132
  • [4] Goldblum JF., 2020, Enzinger and Weiss's Soft Tissue Tumors, V7th
  • [5] Gómez JA, 1999, ARCH PATHOL LAB MED, V123, P503
  • [6] Hanna NN, 1996, J SURG ONCOL, V61, P159, DOI 10.1002/(SICI)1096-9098(199602)61:2<159::AID-JSO13>3.0.CO
  • [7] 2-4
  • [8] Cediranib for Metastatic Alveolar Soft Part Sarcoma
    Kummar, Shivaani
    Allen, Deborah
    Monks, Anne
    Polley, Eric C.
    Hose, Curtis D.
    Ivy, S. Percy
    Turkbey, Ismail B.
    Lawrence, Scott
    Kinders, Robert J.
    Choyke, Peter
    Simon, Richard
    Steinberg, Seth M.
    Doroshow, James H.
    Helman, Lee
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18) : 2296 - U106
  • [9] The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25
    Ladanyi, M
    Lui, MY
    Antonescu, CR
    Krause-Boehm, A
    Meindl, A
    Argani, P
    Healey, JH
    Ueda, T
    Yoshikawa, H
    Meloni-Ehrig, A
    Sorensen, PHB
    Mertens, F
    Mandahl, N
    van den Berghe, H
    Sciot, R
    Dal Cin, P
    Bridge, J
    [J]. ONCOGENE, 2001, 20 (01) : 48 - 57
  • [10] Lakhani S.R., WHO Classification of Tumours of the Breast, VFourth